I am a biotech leader and entrepreneurial drug hunter who has been one of the first employees at multiple Boston-area startup companies with roles spanning across the drug discovery and development spectrum.I am the Senior Vice President of CMC (Chemistry, Manufacturing, and Controls) and Product Development at Rapport Therapeutics, a clinical-stage company leveraging the science of receptor-associated proteins to advance precision neuromedicines.At Third Harmonic Bio, I joined as the third employee during its stealth stage and led a broad range of small molecule development and discovery activities on preclinical and clinical-stage oral KIT inhibitors for allergy and contributed to the company’s successful launch and IPO in 2022. While at Cadent Therapeutics, I managed CMC development, quality, intellectual property, clinical distribution, and other portfolio management functions.At Ataxion Therapeutics, I led the medicinal chemistry program and coordinated its fully-externalized drug discovery model which successfully achieved selection of a development candidate for neurological disorders.Previously at H3 Biomedicine, I headed its flagship drug discovery program on natural product-based splicing modulators into clinical development for hematological cancers.My industrial career of scientific entrepreneurship at biotech companies began at Infinity Pharmaceuticals where I advanced several oncology-focused programs in medicinal and process chemistry capacities.I received my Ph.D. in synthetic organic chemistry from Yale University and I have remained involved with Yale as an elected board member of the Yale Graduate School Alumni Association.My work has been profiled in the alumni magazines of Yale University and Tufts University, and I have received a Young Industrial Investigator Award from the American Chemical Society.Specialties: Drug discovery and development, biotech startup launch, CMC development, drug substance, drug product, medicinal chemistry, external CRO coordination, cross-functional program management, development candidate selection, IND/CTA/IMPD preparation, natural products, GMP manufacturing, regulatory, clinical, business development, quality, formulation, scientific recruiting, intellectual property, venture capital, entrepreneurship